Loading provider…
Loading provider…
Urology Physician in Detroit, MI
NPI: 1336187400Primary Practice Location
KARMANOS CANCER CENTER
4100 John R St, Detroit, MI
Primary Employer
Wayne Health
waynehealthcares.org
HQ Phone
Get MD Michael's Phone Numberphone_androidMobile
Get MD Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
CA State Medical License
1992
MI State Medical License
1995 - 2026
TX State Medical License
1988 - 1992

American Board of Urology
Urology
UCSF School of Medicine
medschool.ucsf.edu
Fellowship • Minimally Invasive Urologic Surgery
1992 - 1995
University of Texas Southwestern Medical Center
Residency • Urology
1988 - 1992
Residency • Surgery
1986 - 1988
WashU Medicine
medicine.washu.edu
Medical School
Until 1986
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 106 | 156 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 85 | 107 |
| 3 | 52000Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 35 | 53 |
| 4 | 81002Urinalysis, manual test | 31 | 34 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 22 | 22 |
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
Authors: Wael Sakr, Edward Gheiler
Journal: Urology
Calculating life expectancy to inform prostate cancer screening and treatment decisions
Lead Sponsor: ImmunityBio, Inc.
Intervention / Treatment: DRUG: N-803, DRUG: N-803 and BCG
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: Canadian Cancer Trials Group
Intervention / Treatment: OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, OTHER: Quality-of-Life Assessment, PROCEDURE: Nephrectomy, OTHER: Patient Observation
Lead Sponsor: University of Michigan Rogel Cancer Center
Collaborators: Michigan Urological Surgery Improvement Collaborative (MUSIC), GenomeDx Biosciences Corp
Intervention / Treatment: OTHER: Decipher Prostate Cancer Classifier